Lanean...
A novel antimetabolite: TAS-102 for metastatic colorectal cancer
TAS-102 is a new oral anti-tumor drug, composed of a thymidine-based nucleoside analog (trifluridine: FTD) and a thymidine phosphorylase inhibitor (tipiracil hydrochloride: TPI). TAS-102 has been shown to significantly improve overall survival and progression-free survival in patients with refractor...
Gorde:
| Argitaratua izan da: | Expert Rev Clin Pharmacol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7485169/ https://ncbi.nlm.nih.gov/pubmed/26677869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/17512433.2016.1133285 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|